Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Novartis
Novartis
Kivu Bioscience Inc.
FindCure Biosciences (ZhongShan) Co., Ltd.
Hoffmann-La Roche
Aveni Foundation
Bayer
University of California, Irvine
Eastern Cooperative Oncology Group
ViroMissile, Inc.
Dana-Farber Cancer Institute
Kaiser Permanente
Washington University School of Medicine
University of Florida
Essen Biotech
MacroGenics
Avacta Life Sciences Ltd
Alliance for Clinical Trials in Oncology
Institut Curie
City of Hope Medical Center
University of Nebraska
Adela, Inc
M.D. Anderson Cancer Center
Ocellaris Pharma, Inc.
University of Southern California
Eli Lilly and Company
Var2 Pharmaceuticals
University of Illinois at Chicago
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Tanabe Pharma America, Inc.
Transgene
Bayer
Memorial Sloan Kettering Cancer Center
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
M.D. Anderson Cancer Center
Young Adult Survivors United
Hadassah Medical Organization
AVM Biotechnology Inc
British Columbia Cancer Agency
Washington University School of Medicine
Valo Therapeutics Oy
Institut Bergonié
Eli Lilly and Company
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Washington University School of Medicine
Institut Bergonié
University of California, Irvine
Instituto do Cancer do Estado de São Paulo